Here, we demonstrated that the combination of NIR-PIT potentiates the effect of NIR-PIT against HER2-positive breast cancer cells, including breast cancer cells with low HER2 expression, trastuzumab-resistant breast cancer cells [17], and brain metastatic breast cancer cells. Here, ERBB2 is linked to breast cancer.